Sue Siegel

Sue Siegel is from San Francisco Bay Area. Sue is currently Chair of the Board of Directors at The Engine, located in Cambridge, MA. Sue also works as Board Member, Committees: Chair, Compensation (2023); Audit (2019-23) (NASDAQ: ILMN) at Illumina, a job Sue has held since Apr 2019. Another title Sue currently holds is Board Member/Trustee, Chair, Investment Committee; Search Committee at KFF. In Sue's previous role as a Board Member, Committees: NomGov | Compensation (NYSE: NVRO) at Nevro (acquired by Globus Medical), Sue worked in Silicon Valley, California, United States until May 2025. Prior to joining Nevro (acquired by Globus Medical), Sue was a Board Member at The Engine and held the position of Board Member at Cambridge, MA. Prior to that, Sue was a Chief Innovation Officer, GE & CEO, GE Business Innovations at GE, based in Menlo Park from Jan 2017 to Jan 2019. Sue started working as CEO, GE Ventures & Licensing at GE in Silicon Valley, CA in Jan 2013. From Jan 2012 to Jan 2017, Sue was CEO, GE Ventures & Healthymagination at GE, based in Silicon Valley, CA. Prior to that, Sue was a Board of Directors at Pacific Biosciences, Inc (NASDAQ:PACB), based in Menlo Park , CA from Jan 2006 to Jan 2013. Sue started working as Board Member; Committee: Compensation at Corventis, Inc in San Jose, California, United States in Jan 2010.